Hatice Bölek

Hatice Bölek: Sunitinib in metastatic renal cell carcinoma

Hatice Bölek, Medical Oncologist at Ankara University School of Medicine, shared her recent article on X:

“Check out the latest publication from the Turkish Oncology Group Kidney Cancer Consortium (TKCC)!

Many thanks to all collaborators.”

Sunitinib in metastatic renal cell carcinoma: clinical outcomes across risk groups in a Turkish Oncology Group Kidney Cancer Consortium

Authors: Hatice Bolek, et al.

Hatice Bölek: Sunitinib in metastatic renal cell carcinoma

cancer fight against cancer Global awareness Global fight against cancer Hatice Bölek OncoDaily Oncology renal cell carcinoma sunitinib TKCC Turkish Oncology Group Kidney Cancer Consortium